|
Miniature Postsynaptic Potentials
|
G07.265.880.750.560 |
|
|
Stress Disorders, Post-Traumatic
|
F03.950.750.500 |
|
|
Beneficence
|
N05.350.958.500 |
|
|
Hepatocyte Nuclear Factor 6
|
D12.776.930.640.500 |
|
|
Onecut Transcription Factors
|
D12.776.930.640 |
|
|
Bioartificial Organs
|
D021522 |
[Artificial organs that are composites of biomaterials and cells. The biomaterial can act as a membrane (container) as in BIOARTIFICIAL LIVER or a scaffold as in bioartificial skin.
] |
|
Anesthesia, Caudal
|
E03.155.086.131.100 |
|
|
Anesthesia, Epidural
|
E03.155.086.131 |
|
|
Ribotyping
|
D021521 |
[RESTRICTION FRAGMENT LENGTH POLYMORPHISM analysis of rRNA genes that is used for differentiating between species or strains.
, A highly specific RIBOTYPING technique used in the analysis of RFLP patterns of rRNA genes to differentiate between organisms at the subspecies level.
, An organism specific restriction pattern (RFLP) of ribosomal RNA genes.
] |
|
Mass Vaccination
|
N06.850.780.680.310.890.500 |
|
|
Nephrolithiasis
|
C12.777.419.600 |
|
|
Sp1 Transcription Factor
|
D12.776.930.375.750.249 |
|
|
Nucleotide Transport Proteins
|
D12.776.157.530.625.875 |
|
|
Voltage-Gated Sodium Channels
|
D12.776.631.960 |
|
|
Netilmicin
|
D09.408.051.374.785.525 |
|
|
Sisomicin
|
D09.408.051.374.785 |
|
|
Prosopagnosia
|
C23.888.592.604.764.100.650 |
|
|
Agnosia
|
C23.888.592.604.764.100 |
|
|
Chloromercuribenzoates
|
D02.455.426.559.389.127.250.311 |
|
|
Nuclear Factor 45 Protein
|
D12.776.930.616.500 |
|
